Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF), were prepared and attached to Ligands through various linkers, including maleimidocaproyl-val-cit-PAB. The resulting ligand drug conjugates were active in vitro and in vivo.

 
Web www.patentalert.com

< Activation and expansion of T-cells using an engineered multivalent signaling platform

> Methods and compositions for using aleveolar macrophage phospholipase A2

> Cleaved serum response factor in cardiac diagnosis and therapy
~ 00502